Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates

Repligen (RGEN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of$ 0.34 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 26.47%. A quarter ago, it was expected that this drug developer would post earnings of$ 0.33 per share when it actually produced earnings of $0.33, delivering no surprise.Over the last four quarters, the company has surpa ...